Arcutis Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Q4 net product revenues for ZORYVE® cream 0.3% were $13.5 million, a 357% increase compared to the fourth quarter of 2022 and a 67% increase compared to the third quarter of 2023; driven by...
United States Latha Vairavan Frank Watanabe Derek Cole Amanda Sheldon Investor Relations Advisory Solutions
Source: marketscreener.com